Latest News
ACTT-EU/UK trial finds remdesivir speeds up COVID-19 recovery
An international clinical trial that is testing the effectiveness of the drug remdesivir on patients hospitalised with Covid-19, has shown “very promising” preliminary results.
Tribute to Lynda Harper
We are all so sad at the Unit about losing our beloved colleague Lynda Harper on 14 April. She was indeed one of the most generous, kind, selfless and wonderful people and we all miss her so much.
Tribute to Gita Ramjee and Emmanuel Harding
Tribute to Gita Ramjee and Emmanuel Harding
Adaptive COVID-19 Treatment Trial recruits first patient
The Adaptive COVID-19 Treatment Trial in EU & UK (ACTT-EU/UK), which is testing treatments for COVID-19, recruited its first patient on 31 March. The trial, which is taking place in around 75 hospitals around the world, will initially test the drug remdesivir. Remdesivir is an antiviral drug that was developed to treat Ebola and Marburg virus infections. In the ACTT-EU/UK ...